Ajanta Pharma's stock is trading at Rs. 2620.00, marking an increase of 97.25 points or 3.85% from its previous close of Rs. 2522.75 on the BSE.

The stock opened at Rs. 2544.75, reaching a high of Rs. 2556.15 and a low of Rs. 2507.00. A total of 2910 shares have been traded so far.

This BSE group 'A' stock, with a face value of Rs. 2, hit a 52-week high of Rs. 2576.25 on July 30, 2024, and a 52-week low of Rs. 1624.80 on July 31, 2023.

In the past week, the stock’s high and low were Rs. 2576.25 and Rs. 2318.45, respectively. The company's current market capitalization stands at Rs. 31,512.20 crore.

Promoters hold 66.27% of the company’s shares, while Institutions and Non-Institutions hold 25.78% and 7.94% respectively.

Ajanta Pharma reported a net profit increase of 11.31% to Rs. 236.03 crore for the first quarter ending June 30, 2024, compared to Rs. 212.04 crore for the same period last year. The company’s total income rose by 5.69% to Rs. 1,105.64 crore for Q1 FY25, up from Rs. 1,046.04 crore in the corresponding quarter of the previous year.

On a consolidated basis, the company’s net profit rose by 18.09% to Rs. 245.77 crore for the quarter ending June 30, 2024, compared to Rs. 208.12 crore for the same period last year. Total income increased by 11.27% to Rs. 1,171.39 crore for Q1 FY25, up from Rs. 1,052.79 crore in the corresponding quarter of the previous year.